The primary findings provided by the ECHO Study will be the comparative risk of HIV acquisition with use of the three contraceptive methods studied. This information will be published and submitted to the World Health Organization for review of its contraceptive guidance. The WHO’s contraceptive guidance is used worldwide by programme managers, policy-makers and clinicians. The study team is committed to ensuring that other stakeholders, particularly study participants and other women at high risk of HIV, have timely access to the information provided by the study. Results will also be presented to national and international policymakers, scientists and advocates.
In addition to data on the risk of HIV acquisition, this study is expected to generate valuable information about contraceptive effectiveness, women’s patterns of use, early HIV-related disease progression among women who seroconvert and additional risk factors for HIV acquisition.